We're proud to report strong global growth with our Q4 & full year 2024 financial results. Our dedication to addressing Afib treatment and post-op pain management continues to drive us forward. Read the full earnings report at: <a href="https://t.co/ebE0q8McEX" target="_blank">https://t.co/ebE0q8McEX</a>
<a href="https://twitter.com/hashtag/Earnings?src=hashtag_click" target="_blank">#Earnings</a> <a href="https://twitter.com/hashtag/FinancialResults?src=hashtag_click" target="_blank">#FinancialResults</a>
- Healthcare Professionals
- Therapies and Procedures
- Concomitant Surgical Ablation Therapy
- Ablation Sensing Unit & Switch Matrix
- cryoFORM® Cryoablation Probe
- cryoICE® BOX V6
- cryoICE® Cryoablation Probes
- Isolator® Linear Pen
- Isolator® Synergy™ Access® Clamp
- Isolator® Synergy™ Clamps (OLL2/OSL2)
- Isolator® Transpolar Pen (MAX3)
- Isolator® Synergy™ EnCompass® Clamp
- Multifunctional Ablation Generator (MAG)
- Hybrid AF™ Therapy
- Hybrid Total Thoracoscopic Therapy
- Left Atrial Appendage Management
- Cryo Nerve Block Therapy
- Concomitant Surgical Ablation Therapy
- Education & Training
- Clinical Evidence
- Product Labeling
- Resources
- Society Guidelines
- Therapies and Procedures
- Patients & Caregivers
- About AtriCure